mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-05 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |